Endoscopy 2025; 57(S 02): S591
DOI: 10.1055/s-0045-1806550
Abstracts | ESGE Days 2025
ePosters

Development of a monitoring strategy for EUS gastroenterostomy in benign indications : a survey of european french-speaking expert echoendoscopists

L Monino
1   Cliniques universitaires Saint-Luc (UCLouvain), Bruxelles, Belgium
2   Hospital Center Universitaire Hospital Saint Eloi, Montpellier, France
,
T Moreels
1   Cliniques universitaires Saint-Luc (UCLouvain), Bruxelles, Belgium
,
J C Valats
2   Hospital Center Universitaire Hospital Saint Eloi, Montpellier, France
,
V Geoffroy
3   Univ-cotedazur.fr, nice, France
,
L Caillo
4   University of Nîmes, Nîmes, France
,
J P Ratone
5   Institute Paoli-Calmettes, Marseille, France
,
A Berger
6   Chu Haut Leveque, Pessac, France
,
F Caillol
5   Institute Paoli-Calmettes, Marseille, France
,
J Branche
7   Centre hospitalier de lille, Lille, France
,
J Jacques
8   CHU Dupuytren 1, Limoges, France
,
E Perez-Cuadrado Robles
9   European Hospital Georges Pompidou, Paris, France
,
N Williet
10   University Hospital of Saint-Étienne, Saint-Priest-en-Jarez, France
,
T Degand
11   Chu Dijon, Dijon, France
,
J F Bourgaux
12   University Hospital of Nimes, Nîmes, France
,
U Chaput
13   Hospital Saint-Antoine Ap-Hp, Paris, France
,
J Privat
14   C.H. de Vichy, Vichy, France
,
R Leenhardt
15   Hospital Saint-Antoine – Ap-Hp Sorbonne University, Paris, France
,
M Schaefer
16   CHRU de Nancy – Hôpitaux de Brabois, NANCY, France
,
T Wallenhorst
17   CHU Rennes – Pontchaillou Hospital, Rennes, France
,
S Godat
18   Lausanne University Hospital, Lausanne, Switzerland
,
S Ouazzani
19   Hospital Erasme HUB, Brussels, Belgium
,
C Snauwaert
20   AZ Sint-Jan, Brugge, Belgium
,
M Palazzo
21   Hopital européen Marseille, rue Désirée, marseille, France
,
B Denis
22   Hopital civils de colmar, Colmar, France
,
A Hedjoudje
23   Hospital Beaujon AP-HP, Clichy, France
,
D Galasso
24   Hospital Riviera-Chablais, Hospital De Rennaz, Lausanne, Switzerland
,
A Badaoui
25   Department of Gastroenterology and Hepatology, CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium
,
P H Deprez
1   Cliniques universitaires Saint-Luc (UCLouvain), Bruxelles, Belgium
,
M Gasmi
26   Hospital Nord, Marseille, France
,
M Barthet
26   Hospital Nord, Marseille, France
,
J M Gonzalez
26   Hospital Nord, Marseille, France
› Institutsangaben
 

Aims EUS-guided gastroenterostomy (EUS-GE) is a minimally invasive procedure to treat gastric outlet obstruction. The lack of standardization in technique still limits its use to high volumes of therapeutic echoendoscopy (expert center). Additionally, the absence of knowledge on long term follow-up prevents extending the indications of EUS-GE to benign pathologies. We conducted a study practices among expert echoendoscopists to identify a dominant strategy for medium and long-term surveillance after performing EUS-GE for benign indication.

Methods An invitation to complete a questionnaire was sent by email with the helping of French society of digestive endoscopy (SFED), to 34 experts from 25 french-speaking centers (19 French centers, 4 Belgian centers and 2 swiss centers). The respondents were asked about the technical aspects of performing EUS-GE and their surveillance strategies for EUS-GE in benign indications.

Results 31 experts responded to this practice questionnaire (91.2%). 14 (45.1%) reported having performed more than 25 EUS-GE procedures regardless of the indication. Among them 6 (6/31, 19.4%) reported having performed more than 7 EUS-GE for benign indications. Since January 2024, 18 participants (58.1%) reported having perfomed between 1 and 3 EUS-GE and 4 participants (12.9%) reported having performed more than 4 EUS-GE for benign procedures. From a technical point, all participants reported using the HotAxios system (Boston Scientific) (31/31, 100%), preferably of 20 mm size (26/31, 83.9%). The method providing the best visibility of the target loop was the oro-intestinal drain for 29 experts (93.5%), associated with the “free hand” method (30/31, 96.8%). 23 (74.2%) experts reported regular follow-up after EUS-GE for benign indications. Among them, 5 proposed follow-up every 3 months (21.7%) and 10 proposed endoscopic follow-up every 6 months (43.5%). A removal strategy was adopted by 13 (41.9%) experts (including 9 at least one year). A replacement strategy was proposed by 13 (41.9%) experts (including 8 at least one year). An adaptable strategy depending on the indication was proposed by the other experts (5, 16.1%). The main criteria precipitating the removal of the LAMS were the regression of the initial pathology (67.9%) or the presence of ulcers (35.7%) or jejunal perforation (42.9%). The main criteria in favour of replacement were LAMS age of more than 6 months (46.5%) or the presence of tissue overgrowth or ingrowth in the LAMS (42.9%).

Conclusions All experts agree on a technique for performing EUS-GE that combines the oro-intestinal drain and “free hand” puncture of the target limb regardless of the indication. A large majority of experts also agree on the need for endoscopic follow-up in patients with EUS-GE for benign pathologies. The results of this survey help identify the follow-up elements and removal/replacement strategies used by all experts. These data help refine the protocols for future studies on EUS-GE for benign indications.



Publikationsverlauf

Artikel online veröffentlicht:
27. März 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany